Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Calcipotriene
Drug ID BADD_D00334
Description Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.
Indications and Usage For the treatment of moderate plaque psoriasis in adults.
Marketing Status Prescription; Discontinued
ATC Code D05AX02
DrugBank ID DB02300
KEGG ID D01125
MeSH ID C055085
PubChem ID 49800068
TTD Drug ID D01QUS
NDC Product Code 68462-501; 51672-5278; 0168-0400; 50222-260; 16714-763; 51862-512; 0713-0318; 51862-376; 51407-606; 40032-043; 63415-0052; 50383-732; 58272-197; 73309-104; 0781-7117; 51672-4154; 66993-878; 71052-476; 51407-605; 54239-005; 68462-310; 66993-877; 0115-1475
Synonyms calcipotriene | calcipotriol | 1,24(OH)2-22-ene-24-cyclopropyl D3 | Psorcutan | Sorilux | PRI-2205 | heximar win care | Dovonex | Daivonex | MC 903 | MC-903
Chemical Information
Molecular Formula C27H42O4
CAS Registry Number 147657-22-5
SMILES CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C.O
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Application site erythema08.02.01.001; 12.07.01.001; 23.03.06.005--Not Available
Application site pain08.02.01.004; 12.07.01.004--Not Available
Burning sensation08.01.09.029; 17.02.06.001--Not Available
Dermatitis23.03.04.002--Not Available
Dry skin23.03.03.001--
Erythema23.03.06.001--Not Available
Folliculitis11.01.12.018; 23.09.04.007--
Hypercalcaemia05.04.01.002; 14.04.01.003--
Hypersensitivity10.01.03.003--
Instillation site pain08.02.01.008; 12.07.01.008--Not Available
Pain08.01.08.004--
Paraesthesia17.02.06.005--
Pruritus23.03.12.001--
Psoriasis10.02.01.036; 23.03.14.002--Not Available
Rash23.03.13.001--Not Available
Skin atrophy23.01.05.001--
Skin exfoliation23.03.07.003--Not Available
Skin hyperpigmentation23.05.01.003--
Skin irritation23.03.04.009--Not Available
Koebner phenomenon23.03.03.058--Not Available
The 1th Page    1    Total 1 Pages